CA2145763A1 - Pharmaceutical compositions containing nonionic surfactants - Google Patents

Pharmaceutical compositions containing nonionic surfactants

Info

Publication number
CA2145763A1
CA2145763A1 CA002145763A CA2145763A CA2145763A1 CA 2145763 A1 CA2145763 A1 CA 2145763A1 CA 002145763 A CA002145763 A CA 002145763A CA 2145763 A CA2145763 A CA 2145763A CA 2145763 A1 CA2145763 A1 CA 2145763A1
Authority
CA
Canada
Prior art keywords
active agent
nonionic surfactant
polyoxyethylene
composition according
ethoxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002145763A
Other languages
English (en)
French (fr)
Inventor
William J. Curatolo
Michael J. Gumkowski
Julian Belknap Lo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2145763A1 publication Critical patent/CA2145763A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002145763A 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants Abandoned CA2145763A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95596292A 1992-10-02 1992-10-02
US07/955,962 1992-10-02

Publications (1)

Publication Number Publication Date
CA2145763A1 true CA2145763A1 (en) 1994-04-14

Family

ID=25497602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002145763A Abandoned CA2145763A1 (en) 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants

Country Status (12)

Country Link
EP (1) EP0662826A1 (no)
JP (1) JPH07507565A (no)
KR (1) KR950703333A (no)
AU (1) AU5095393A (no)
CA (1) CA2145763A1 (no)
FI (1) FI934317A (no)
HU (1) HUT69400A (no)
IL (1) IL107084A0 (no)
MX (1) MX9306125A (no)
TW (1) TW253838B (no)
WO (1) WO1994007472A1 (no)
ZA (1) ZA937268B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
SE9602145D0 (sv) * 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
JP5300477B2 (ja) * 2006-08-01 2013-09-25 大塚製薬株式会社 薬理活性物質の吸収性が改善された医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS6233128A (ja) * 1985-08-07 1987-02-13 Toray Ind Inc インタ−フエロン腸溶性経口用製剤
EP0351651B1 (en) * 1988-07-21 1993-09-15 F. Hoffmann-La Roche Ag Insulin preparation
AU1256692A (en) * 1991-02-06 1992-09-07 Schering Corporation Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor
CA2125400A1 (en) * 1991-12-18 1993-06-24 Gordon L. Amidon Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Also Published As

Publication number Publication date
IL107084A0 (en) 1993-12-28
HUT69400A (en) 1995-09-28
WO1994007472A1 (en) 1994-04-14
FI934317A (fi) 1994-04-03
JPH07507565A (ja) 1995-08-24
HU9302774D0 (en) 1993-12-28
KR950703333A (ko) 1995-09-20
FI934317A0 (fi) 1993-10-01
AU5095393A (en) 1994-04-26
ZA937268B (en) 1995-03-30
MX9306125A (es) 1994-04-29
TW253838B (no) 1995-08-11
EP0662826A1 (en) 1995-07-19

Similar Documents

Publication Publication Date Title
EP0843558B1 (en) Composition for enhanced uptake of polar drugs from the colon
RU2198677C2 (ru) Фармацевтическая композиция для пероральной доставки физиологически активного пептидного агента и способ усиления его биодоступности
Nicolaos et al. Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion
EP0387352B1 (en) Enteric formulations of physiologically active peptides and proteins
EP0736041A1 (en) Transparent liquid for encapsulated drug delivery
US4889723A (en) Pharmaceutical compositions comprising esters or amides as active ingredients
EP2062571B1 (en) Self-emulsifying pharmaceutical composition with enhanced bioavailability
JP2005225897A (ja) サイクロスポリンａを含む無油医薬組成物
JPH0840936A (ja) 経口投与薬物のための製剤
CA2145763A1 (en) Pharmaceutical compositions containing nonionic surfactants
JPH04247026A (ja) 下部消化管崩壊経口製剤
US11185589B2 (en) Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
WO1995006463A1 (en) Pharmaceutical compositions containing anionic surfactants
US6979672B2 (en) Cyclosporin-based pharmaceutical compositions
EA046567B1 (ru) Композиция для пероральной доставки гидрофильных синтетических или природных молекул со слабой проницаемостью

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued